Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hodgkin's or Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01421173
What this trial is testing

Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 78
Early research (Phase 1)Study completedNCT00118170
What this trial is testing

Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+42 more
National Cancer Institute (NCI) 150
Early research (Phase 1)Study completedNCT03009344
What this trial is testing

Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Eisai Co., Ltd. 7
Testing effectiveness (Phase 2)Study completedNCT01388959
What this trial is testing

MabThera/Rituxan (Rituximab) in Patients With Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 40
Early research (Phase 1)Study completedNCT01055496
What this trial is testing

Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, B-Cell
Pfizer 103
Large-scale testing (Phase 3)WithdrawnNCT00319332
What this trial is testing

A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen

Who this might be right for
Lymphoma, Small Cleaved-Cell, FollicularLymphoma, Large-Cell, FollicularLymphoma, Follicular+1 more
GlaxoSmithKline
Testing effectiveness (Phase 2)UnknownNCT01811368
What this trial is testing

Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Refractory Non Hodgkin LymphomaRelapsed Non Hodgkin Lymphoma
Joseph Tuscano 20
Testing effectiveness (Phase 2)Ended earlyNCT00655668
What this trial is testing

A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma

Who this might be right for
T-cell Non-Hodgkin's Lymphoma
Celgene 54
Testing effectiveness (Phase 2)Study completedNCT00021372
What this trial is testing

Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Fox Chase Cancer Center 25
Very early researchLooking for participantsNCT04603872
What this trial is testing

CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, RefractoryAcute Lymphoblastic Leukemia, in Relapse+3 more
Zhejiang University 120
Early research (Phase 1)Study completedNCT00718757
What this trial is testing

Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies

Who this might be right for
Non-Hodgkins LymphomaHodgkin's DiseaseAcute Lymphoblastic Leukemia
St. Jude Children's Research Hospital 4
Large-scale testing (Phase 3)UnknownNCT00003728
What this trial is testing

Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
European Organisation for Research and Treatment of Cancer - EORTC 1,500
Early research (Phase 1)Ended earlyNCT00674427
What this trial is testing

Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant

Who this might be right for
Chronic Myelogenous LeukemiaAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+5 more
University of Pennsylvania 13
Testing effectiveness (Phase 2)Study completedNCT00002348
What this trial is testing

Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinHIV Infections
Genzyme, a Sanofi Company
Early research (Phase 1)Study completedNCT00659425
What this trial is testing

CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaNon-Hodgkin's Lymphoma
MedImmune LLC 57
Testing effectiveness (Phase 2)WithdrawnNCT00003663
What this trial is testing

Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Hoag Memorial Hospital Presbyterian
Testing effectiveness (Phase 2)Study completedNCT00220285
What this trial is testing

Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaLymphoma, B-CellLymphoma, Low-Grade
Bayer 45
Testing effectiveness (Phase 2)Study completedNCT00071955
What this trial is testing

Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Genitope Corporation
Testing effectiveness (Phase 2)Study completedNCT00550615
What this trial is testing

Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
University of Nebraska 38
Testing effectiveness (Phase 2)UnknownNCT04553393
What this trial is testing

Decitabine-primed Tandem CD19/CD20 CAR T Cells Plus Epigenetic Agents in Aggressive r/r B-NHL With Huge Tumor Burden

Who this might be right for
Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden
Chinese PLA General Hospital 80
Next Page